Nick Duncan

Contributor

Nick.Duncan@uhb.nhs.uk

Consultant haematology pharmacist, Pharmacy department, Queen Elizabeth Hospital, Birmingham, UK

Treatment of acute and chronic lymphoid leukaemia

Pharmacists should be able to describe the differences between acute lymphoblastic and chronic lymphocytic leukaemia and the available treatment.…

Multiple myeloma: pharmacological management

Although multiple myeloma is currently regarded as being incurable in the majority of patients, the outlook for patients diagnosed with the condition has improved markedly over the past 40 years, with survival rates quadrupling. Significant advances in both treatment and supporti…

Lymphomas: current and future treatment options

The management of lymphomas involves a range of different chemotherapy schedules, with novel medicines emerging and offering better treatment options.…

Lymphomas: pathogenesis, clinical features and diagnosis

Lymphomas are some of the most common cancers in the UK, with a wide variation in disease progression and prognosis between subtypes.…

Adult myeloid leukaemias: current and future treatments

Acute myeloid leukaemia is treated with chemotherapy and, if appropriate, stem cell transplantation. For those with chronic myeloid leukaemia, therapy has been transformed by tyrosine kinase inhibitors…